Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Corticosteroids Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/31/2021 13 8
Convalescent plasma Emergency use authorization Experimental Antiviral Mar/30/2021 33 6
Ribavirin Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/25/2021 10 2
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Mar/19/2021 23 7
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/08/2021 40 43
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/08/2021 25 7
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/01/2021 26 15
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Feb/12/2021 26 14
Sorafenib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/09/2021 2 0
Arbidol Recommended by China's NHC Guidelines Used to treat other disease Antiviral Jan/25/2021 13 3